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Immunoenzymatic dot-blot test for the diagnosis of 
enteric fever caused by Salmonella typhi in an 
endemic area 
Nora  Cardona-  Castro and  Piedad Agudelo-  FMrex 
Laboratorio de  Microbiologia, Instituto Colombiano de Medicina Tropical, Medellin, Colombia 
Objective: To develop a quick, solid-phase immunoenzymatic test, dot blot, to diagnose typhoid fever by the detection 
of IgG and IgM antibodies against three Salmonella typhi antigens (lipopolysaccharide, crude and flagellar) and to 
compare the dot-blot test with an enzyme-linked immunosorbent assay (ELISA) using the same antigens and with the 
Widal agglutination test. 
Methods: Blood culture was used as the definitive test. All tests were used for the study of the sera from three groups 
of individuals: 33 patients suffering typhoid fever, diagnosed by isolation of S. typhi in blood culture; 35 patients with 
other enterobacterial infections documented by culture; and 156 asymptomatic volunteers, all residents of the same 
endemic region (Uraba, Colombia). 
Results: The best diagnostic efficiency was obtained by detecting IgG against a flagellar antigen dot blot, giving a 
sensitivity and specificity of 88%. Widal and ELISA tests showed lower diagnostic efficiencies. 
Conclusions: The dot-blot test may be useful to diagnose typhoid fever in rural areas lacking technological resources 
with which to carry out blood cultures or ELlSA tests. The visual reading makes this test practical and cheap for these 
regions. 
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I NTRO D U CTI 0 N 
Typhoid fever is still a public-health problem in 
developing countries, where it is endemic and may 
have an annual incidence as high as 500 cases per 
100 000 inhabitants [l]. 
In Colombia, the prevalence of this disease is great, 
although not exactly defined. Even though reports of 
epidemic outbreaks have been published, there is 
an absence of reliable data due to under-reporting and 
the difficulty of accurate diagnosis. Most cases are 
clinical appreciations without laboratory confirmation. 
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Estimates of the incidence of salmonellosis depend on 
reporting techniques. Studies indicate that only about 
one in 100 cases of salmonellosis is diagnosed and 
reported [ 11. 
Diagnosis is considered conclusive when the bac- 
terium is isolated from blood or bone marrow cultures. 
Without proper antibiotic treatment, 80% of patients 
give positive blood cultures during the first week of the 
illness and 20-30% continue to show positive blood 
cultures until the third week of infection. Bone marrow 
cultures give positive results in 90% of patients with 
typhoid and paratyphoid fever, this being the most 
effective method for isolating the bacteria [l-31. The 
Widal test, known to lack reliable sensitivity and 
specificity, is still used extensively due to its simplicity 
1431. 
In the search for better diagnostic tests for 
salmonella infections, other methods have been used: 
counterimmunoelectrophoresis [6], ELISA tests using 
different antigens [7-131, immunoblotting using lipo- 
polysaccharide and flagellar antigens [ 141, dot enzyme 
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immunoassay using outer-membrane proteins [ 151, 
immunoff uorescence [16-19], etc. These tests generally 
have a higher sensitivity and specificity than the Widal 
test. Most of these tests are not widely available and 
require complex techniques and equipment. 
Therefore, there is a need for a rapid, reliable and 
accessible method for use in endemic areas, with limited 
health services and laboratory resources, which has 
greater sensitivity and specificity than the Widal test. 
MATERIALS AND METHODS 
Patients 
Patients older than 18 years admitted with fever to the 
Service of Internal Medicine of the Regional Hospital 
in Apartad6, Colombia, from 1993 to 1995 were con- 
sidered in the study. All patients admitted had venous 
blood taken for triplicate cultures, ELISA, and dot-blot 
and Widal tests. Urine and stool specimens were also 
collected for culture before treatment. These cultures 
were processed in the Laboratory of Microbiology of 
the Instituto Colombiano de Medicina Tropical, 
Apartad6, Colombia. 
For the purpose of analysis, subjects were classified 
into three groups. Group 1 comprised 33 individuals 
with features of typhoid fever and isolation of S. typhi 
from blood culture. Group 2 comprised 35 individuals 
with enterobacterial infection different from S. typhi 
enteric fever. The infections were urinary tract 
infection, septicemia or gastroenteritis confirmed by 
culture as being caused by Escherichia coli (21), Klebsiella 
spp. (6), Protetrs spp. (2), Enterobacter spp. (4) and S. 
enteritidis (2). Group 3 comprised 156 healthy, asympto- 
matic volunteers, all residents of the same endemic 
region of Urabi. 
Bacterial isolation 
Blood cultures were incubated in trypticase soy broth 
(Becton Dickmson and Company, Cockeysville MD, 
USA) for 7 days at 37OC. Subcultures on blood agar 
were made on days 1 ,  3, 5 and 7. The organisms were 
identified on the basis of biochemical reactions and 
agglutination with specific antisera (Wellcome 
Reagents, Kent, England) [20]. Urine and feces cul- 
tures were performed according to standard techniques 
P O I .  
Widal test 
Agglutination against somatic antigen (0) and flagellar 
antigen (H) from S. typhi and flagellar antigen from S. 
paratyphi A and S. paratyphi B were tested by the rapid 
slide method (Cenogenics Co., Morganville, Nj, USA). 
The following volumes of serum (including positive 
and negative control sera) were tested: 0.08 mL, 
0.04 mL, 0.02 mL, 0.01 mL and 0.005 mL; the serum 
dilutions in the slide test are approximately equivalent 
to the tube test dilutions 1 : 20, 1 : 40, 1 : 80, 1 : 160 
and 1 : 320 respectively. A positive serum of known 
titer and a negative serum were included as controls. 
The test was considered positive when the agglutin- 
ation titer was greater than or equal to 1 : 80 [4,5]. 
Rheumatoid factor detection 
Rheumatoid factor detection was carried out on all the 
serum samples tested, using the latex test (Behring 
RapiTex-FR Cod 3370 Werke AG, Marburg-Lahn, 
Germany), to detect possible false positives for IgM. 
Two positive serum samples for this factor were 
absorbed with the reactive agent RF-Absorbent 
(Behring Werke AG, Marburg-Lahn, Germany). 
Strains 
An S. typhi 1966 strain &om the Instituto Nacional de 
Salud (INS) and a 1991 strain isolated from the blood 
culture of an enteric fever patient from Apartad6 
(Urabi region) were used to obtain bacterial antigens. 
Antigen isolation 
Crude antigen was obtained by the procedure 
developed by Schnaitman [21]. From an overnight S. 
typhi culture, a colony was selected and subcultured in 
10 mL of nutrient broth (BBL Microbiology Systems, 
Cockeysville, MD, USA) for 18 h at 37OC; 1 mL of this 
suspension was then subcultured in 40 mL of nutrient 
broth and incubated for 4 h at 37OC in a rotating 
agitator. The bacteria were washed three times with 
distilled water and then frozen at -20°C. After 
thawing, the sediment was mixed with 2% sodium 
dodeclysulfate and 50 mM Tris (Sigma Chemical Co., 
St Louis, M O  63178, USA), and incubated in a rotating 
agitator at 37°C for 1 h. After washing by centri- 
fugation, the pellet was resuspended in 10 mL distilled 
water and dispensed into 1-mL aliquots, frozen and 
lyophilized. The effectiveness of bacterial lysis was 
tested by plating the bacterial lysate on nutrient agar 
plates at the end of each process. Protein concentration 
was determined by the Lowry method [22]. 
Flagellar antigen was purified by the previously 
described method [23]. A colony of S. typhi obtained 
from an overnight culture was inoculated in nutrient 
broth and incubated overnight at 37°C. Five milliliters 
were subcultured in 200mL of nutrient broth in a 
rotating agitator for 4 h at 37°C. Subsequently, the 
culture was washed and centrifuged twice at 40008 for 
15 min at 4°C. The pellet was resuspended in saline 
solution and disintegrated (Tekmar Tissuemixer, 
Cincinatti, Ohio, USA). The product was washed in 
saline solution, centrifuged at 5000g for 25 min at 4 O C  
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to remove bacterial debris and resuspended in saline 
solution. After centrifugation at 75 OOOg for 45 min, 
the sediment was resuspended in saline solution with 
thinierosal (Sigma T8784 Chemical Company 
Milwaukee, WI 53201, USA). To dissociate the flagella, 
the suspension was acidified with 1 M HCI for 30 miri 
a t  room temperature. It was then centrifuged at 80 0009 
for 60 niin and the supernatant was carefully removed 
and neutralized with 1 M NaOH. To polymerize the 
flagellar protein, two volumes of cold saturated 
ammonium sulfate solution (70% w/v) were added. 
This mixture was left for 16 h at I0C,  and then 
centrifuged a t  20 OOOg for 15 min. The sediment was 
resuspended in distilled water, dialyzed to extract the 
ammonium sulfate, and then kept lyophilized [23). The 
protein concentration was determined by the Lowry 
method 1221. 
Lipopolysaccharide (LPS) antigen from S. typhi was 
obtained commercially (Sigma Chenlical Co., St Louis, 
MO, USA). 
Enzyme-linked immunosorbent assay (ELISA) 
Both antigens and control sera were standardized to 
determine clearcut positive and negative reactions 
124,251. ELISA tests were performed following 
standard procedures 1221. Immulon I was used covered 
with lOOpL/mL of crude, flagellar or LPS antigen 
(Dynatech Laboratories, Inc., Chantilly, VA, USA). 
Goat antihuman IgG and IgM antibodies labeled with 
peroxidase were used uackson Immunoresearch 
Laboratories, Inc., West Baltimore Pike, West Grove, 
PA, USA); o-phenylenediainine (OPD) was used as 
substrate (Sigma Chemical Co., St Louis, MO, USA); 
reading was carried out at  450 nm [22,26]. A reaction 
was scored as positive if the absorbance reading was 
equal to or greater than three standard deviations of the 
average abrorbance of negative control sera [27]. 
Dot-blot protocol 
One hundred microliters per well of 1.25 pg/niL crude 
or LPS antigen or 1 pg/mL flagellar antigen were 
dotted onto nitrocellulose paper placed in a Bio Dot 
Microfiltration Apparatus (Bio-Rad Laboratories, 
Richmond, CA, USA). The membrane was blocked 
with 200 pL/well of fetal bovine serum with 1% Tris 
buffer saline (TBS) (FBS-TBS). The serum samples 
were added and left to filter by gravity, and then 100 pL 
of goat antihuman anti-IgG or anti-IgM was added and 
allowed to drain by gravity. Finally, 100 pL of the 
substrate dianiinobenzidine (Sigma Chemical Co., St 
Louis, MO, USA) was added and the mixture was 
incubated for 20min. The reaction was stopped by 
washing the wells with distilled water under a vacuum. 
The membrane was left to dry for the final color 
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controls were run in 1 : 25 to 1 : 800 dilutions. A brown 
color similar to that of the posltive control in a dilution 
2 1 : 100 were considered positive. Patients 1, 2 and 3 were 
positive for fgG and patient 1 was positive for IgM. 
Serum samples and posltive and negative 
visualization reading. The reaction was positive if a 
brown color, similar to that in the positive control, was 
observed. The reaction was negative if a pink color, 
similar to that in the negative control, was present 
(Figure 1). The serum samples and positive and 
negative controls were run in 1 : 25 to 1 : 800 dilutions 
[22,28]. A reaction was scored as positive when the titer 
was greater than or equal to 1 : 100. 
Statistical analysis 
All subjects were used to calculate the sensitivity, 
specificity, positive predictive value and negative 
predictive value according to the screening test [27,29]. 
RESULTS 
Widal tests 
In group 1 (S. typlri-infected patients), only two (6%) 
of the patients showed specific positive Widal tests 
(Ago and/or AgH from S. typhi only). Twenty-four 
patients (73%) showed agglutination for one ( S .  
yuratyplii A AgH or S.  paratyphi B AgH), several 
(including S. typhi AgO and AgH) or all agglutinins 
tested (non-specific agglutination), and seven (21 5%) 
were negative. In group 2 (other Enterobacteriaceae- 
infected patients) 10 (28.5%) had Widal tests positive 
for one, some or all agglutinins tested. In group 3 
(asymptomatic volunteers), 29 (1 8.6%)) were positive for 
one or some agglutinins tested (Table 1). The sensitivity 
of the Widal test is 44%, the specificity is 20.4%, the 
positive predictive value is 40%, and the negative 
predictive value is 96'K. 
Dot-blot and ELISA tests 
Table 2 shows the sensitivity, specificity, positive 
predictive value and negative predictive value for the 
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Table 1 Percentage of patients with different results of the Widal test 
S. paratypki A 
AgH and/or 
S. pnratypki B AgH 
and/or S. typhi S. typhi A g o  
Group and/or AgH A@ and/or AgH‘ Agglutination 
patientsa onlyb (“Yo) (“A) negative (%) 
Group 1 6 73 21 
Group 2 14 19 67 
Group 3 12 19 69 
67 
~ ~~ ~ ~ 
”Group 1, typhoid fever patients; group 2, other enterobacterially infected patients; 
group 3, asymptomatic volunteers. 
bSpecific Widal test. 
“on-specific Widal test. 
Table 2 
and dot-blot tests 
Test/Ag used/Ab detected s (%) SP (%) PPV (%) NPV (“Yo) 
Sensitivity ( S ) ,  specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) of the ELISA 
ELISA/crude Ag/IgGa 
ELISA/crude Ag/IgM 
ELISA/flageUar Ag/IgG 
ELISA/flageUar Ag/IgM 
ELISA/LPS Ag/IgG 
ELISA/LPS Ag/IgM 
Dot blot/crude Ag/IgG 
Dot blot/crude Ag/lgM 
Dot blot/flageUar Ag/IgG’ 
Dot blodflagellar Ag/IgM 
Ilot blot/LPS Ag/IgG 
Dot blot/LPS Ag/IgM 
Widal test 
51.5 
24.0 
18.0 
21.0 
33.3 
18.1 
3.0 
3.0 
88.0 
12.1 
6.0 
12.1 
44.0 
69.0 
92.0 
78.5 
80.6 
91.0 
97.4 
100.0 
100.0 
88.0 
97.0 
100.0 
97.0 
20.4 
22.0 
35.0 
13.0 
16.0 
39.3 
54.5 
100.0 
100.0 
56.0 
10.0 
100.0 
40.0 
40.0 
89.0 
87.6 
84.7 
85.5 
89.0 
87.3 
85.7 
85.7 
97.7 
86.4 
86.0 
86.4 
96.0 
,‘Tests which had higher sensitivity than the Widal test. 
ELISA and dot-blot assays, which were standardized 
and compared with the Widal test. The best test was 
the dot-blot test detecting IgG against flagellar antigen, 
with a sensitivity and specificity of 88%. In group 1 (S. 
ryphi-infected patients), 84.8% had positive dot blots for 
IgG antibodies against flagellar antigen, in group 2 
(other Enterobacteriaceae-infected patients), 37% were 
positive for the same test, and in group 3 (asymptomatic 
volunteers), 7% were positive. The dot-blot test 
detecting IgM against flagellar antigen had a lower 
sensitivity (12.1%) than the Widal test but a higher 
specificity (97%) (Table 2). 
DISCUSSION 
The diagnosis of enteric fever caused by S. typhi 
represents a problem for clinicians, laboratory tech- 
nicians and epidemiologists. A conclusive diagnosis is 
made by isolation of S. typhi blood cultures or bone 
marrow cultures, given that isolating bacteria from the 
feces is not diagnostic in endemic areas, although it can 
constitute strong evidence in patients with typical 
clinical features [l]. 
Although other methods have been used to diag- 
nose salmonella infections, these tests are usually not 
available in endemic areas. In addition, the equipment 
and techniques required need an infrastructure that in 
most rural regions of Colombia does not exist. There 
is a clear need for rapid, reliable and accessible methods 
that can be used in endemic areas where resources for 
health services and laboratories are limited. 
An ideal test for the diagnosis of typhoid fever in 
endemic areas should be sensitive, specific, rapid, simple 
and inexpensive. The Widal test has some of these 
characteristics, but lacks sensitivity and specificity. 
Choo et a1 [15] found that the Widal test had a 
sensitivity and specificity of 97.6% and 66.7%, 
respectively. They used the test on children in an 
epidemic period; all children admitted with fever had 
venous blood taken for duplicate cultures, dot-blot test 
and Widal test. We found the Widal test to have a 
sensitivity and specificity of 44% and 20.4%, 
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respectively, at the same time of sampling used by Choo 
[ 151. The difference in results was probably due to the 
population studied (age, geographic area) and the 
epidemic period. 
The dot-blot sensitivity and specificity obtained 
by Choo using a 50-kDa outer-membrane protein of 
S. typhi to detect IgG antibodies were 95% and 75% 
respectively [15]; similar results were obtained with the 
dot blot test using flagellar antigen. The sensitivity and 
specificity of the dot blot test using flagellar antigen 
could be increased by combining it with the dot blot 
test to detect IgM antibodies against the same antigen. 
Such a combination could improve diagnostic effi- 
ciency while at  the same time making it possible to 
interpret the stage of the patient’s infection. The  dot 
blot test is very simple and the visual reading of results 
makes it useful for studies in the field. 
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